Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
103 hedge funds and large institutions have $279M invested in Aratana Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 28 reducing their positions, and 10 closing their positions.
1,283% more call options, than puts
Call options by funds: $166K | Put options by funds: $12K
110% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 10
64% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 28
12% more funds holding
Funds holding: 92 → 103 (+11)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
35% less capital invested
Capital invested by funds: $429M → $279M (-$150M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$31M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$17M |
| 3 |
Jennison Associates
New York
|
+$12.1M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$11.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$7.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$16.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.92M |
| 3 |
SCM
Sio Capital Management
New York
|
-$4.48M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$3.02M |
| 5 |
HHC
Hutchin Hill Capital
New York
|
-$2.99M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
SEI Investments
Oaks,
Pennsylvania
| $3K | +$5.01K | +296 | New |
|
|
LTFS
102
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | +$3.37K | +199 | New |
|
103
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1.48K | +$2.61M | +154,440 | +777% |
|
|
IHM
104
Iguana Healthcare Management
New York
| – | -$3.02M | -200,000 | Closed |
|
105
D.E. Shaw & Co
New York
| – | -$779K | -51,492 | Closed |
|
|
FMA
106
FNY Managed Accounts
New York
| – | -$348K | -23,000 | Closed |
|
|
SCA
107
Secor Capital Advisors
New York
| – | -$259K | -17,097 | Closed |
|
|
OC
108
Oppenheimer & Co
New York
| – | -$211K | -14,000 | Closed |
|
|
EMG
109
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$192K | -12,700 | Closed |
|
|
CSS
110
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$180K | -11,922 | Closed |
|
|
BCI
111
Brinker Capital Investments
Berwyn,
Pennsylvania
| – | -$100K | -6,636 | Closed |
|
112
Invesco
Atlanta,
Georgia
| – | -$6K | -392 | Closed |
|
PETX Hedge Fund Activity: Q3 2015 in Review
103 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q3 2015, worth a combined $279M — down 35% from $429M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new PETX positions and 10 closed out — a net gain of 11 holders — while 46 added to existing stakes and 28 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $31M. The largest seller was MPM Asset Management, cutting an estimated $16.9M.
- 103 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q3 2015, up from 92 in Q2 2015.
- Funds reported $279M of Aratana Therapeutics, Inc. stock for Q3 2015, down 35% quarter-over-quarter.
- 21 funds opened new Aratana Therapeutics, Inc. positions in Q3 2015 and 10 closed out, a net change of +11 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q3 2015 was Wellington Management Group, an estimated $31M added.
- The largest Aratana Therapeutics, Inc. seller in Q3 2015 was MPM Asset Management, an estimated $16.9M sold.
Based on aggregated 13F filings for Q3 2015.